These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33647769)

  • 1. Pharmacological advances in mitochondrial therapy.
    Singh A; Faccenda D; Campanella M
    EBioMedicine; 2021 Mar; 65():103244. PubMed ID: 33647769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues.
    Orsucci D; Mancuso M; Ienco EC; LoGerfo A; Siciliano G
    Curr Med Chem; 2011; 18(26):4053-64. PubMed ID: 21824087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of pharmacological strategies for mitochondrial disorders.
    Kanabus M; Heales SJ; Rahman S
    Br J Pharmacol; 2014 Apr; 171(8):1798-817. PubMed ID: 24116962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial medicine for aging and neurodegenerative diseases.
    Reddy PH
    Neuromolecular Med; 2008; 10(4):291-315. PubMed ID: 18566920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic.
    Scatena R; Bottoni P; Botta G; Martorana GE; Giardina B
    Am J Physiol Cell Physiol; 2007 Jul; 293(1):C12-21. PubMed ID: 17475665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant modulation in restoring mitochondrial function in neurodegeneration.
    Pahrudin Arrozi A; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S
    Int J Neurosci; 2017 Mar; 127(3):218-235. PubMed ID: 27074540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting antioxidants to mitochondria and cardiovascular diseases: the effects of mitoquinone.
    Milagros Rocha M; Victor VM
    Med Sci Monit; 2007 Jul; 13(7):RA132-45. PubMed ID: 17599037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial Dynamics: Molecular Mechanisms, Related Primary Mitochondrial Disorders and Therapeutic Approaches.
    Di Nottia M; Verrigni D; Torraco A; Rizza T; Bertini E; Carrozzo R
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33578638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial pharmacology.
    Smith RA; Hartley RC; Cochemé HM; Murphy MP
    Trends Pharmacol Sci; 2012 Jun; 33(6):341-52. PubMed ID: 22521106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia polarization by mitochondrial metabolism modulation: A therapeutic opportunity in neurodegenerative diseases.
    Di Stadio A; Angelini C
    Mitochondrion; 2019 May; 46():334-336. PubMed ID: 30243831
    [No Abstract]   [Full Text] [Related]  

  • 12. [MITOCHONDRIAL DYSFUNCTION: MODERN ASPECTS OF THERAPY (REVIEW)].
    Arveladze G; Geladze N; Khachapuridze N; Bakhtadze S; Kapanadze N
    Georgian Med News; 2015; (244-245):78-84. PubMed ID: 26177139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
    Haas RH
    Mitochondrion; 2007 Jun; 7 Suppl():S136-45. PubMed ID: 17485245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials in mitochondrial disorders, an update.
    Almannai M; El-Hattab AW; Ali M; Soler-Alfonso C; Scaglia F
    Mol Genet Metab; 2020; 131(1-2):1-13. PubMed ID: 33129691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits.
    Geromel V; Darin N; Chrétien D; Bénit P; DeLonlay P; Rötig A; Munnich A; Rustin P
    Mol Genet Metab; 2002; 77(1-2):21-30. PubMed ID: 12359126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome.
    Valenti D; de Bari L; De Filippis B; Henrion-Caude A; Vacca RA
    Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():202-17. PubMed ID: 24548784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties.
    Kelso GF; Porteous CM; Coulter CV; Hughes G; Porteous WK; Ledgerwood EC; Smith RA; Murphy MP
    J Biol Chem; 2001 Feb; 276(7):4588-96. PubMed ID: 11092892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial medicine for neurodegenerative diseases.
    Du H; Yan SS
    Int J Biochem Cell Biol; 2010 May; 42(5):560-72. PubMed ID: 20067840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial pharmacology: its future is now.
    Szeto HH; James LP; Atkinson AJ
    Clin Pharmacol Ther; 2014 Dec; 96(6):629-33. PubMed ID: 25399706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
    Beal MF
    J Bioenerg Biomembr; 2004 Aug; 36(4):381-6. PubMed ID: 15377876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.